Pharma Journalist - Page 712 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Celgene and Juno Therapeutics sign definitive merger agreement

Seattle Genetics asserted EC’s extension of marketing authorization for ADCETRIS

Enzo Biochem testifies Cervical Cancer Biomarker detection test

FDA approves Ready-to-Use Cardiovascular Medication Bivalirudin for Baxter

FDA offers supplementary clearances to Bio-Rad’s IH-System Gel Reagents, Blood Typing Products

FDA extends Orphan Drug Designation to Enzychem Lifesciences’s EC-18 for treatment of ARS

Astellas Pharma and Vical asserts negative Phase 3 Clinical Trial results for ASP0113 for CMV-HSCT recipients

Agenus launches its Clinical Trial combination of its anti-CTLA4 (AGEN1884) and anti-PD1 (AGEN2034) antibodies